Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pedro Mata

Showing results (71-80 of 144) with videos related to

Pageof 15
Sort By:
Journal of Clinical Lipidology|July 29, 2022
Predicting resilience in heterozygous familial hypercholesterolaemia: A cohort study of octogenarian patientsLeopoldo Pérez de Isla, Rodrigo Alonso, Rosa Argüeso, et al.
Diagnostics (Basel, Switzerland)|September 14, 2024
Total Cholesterol Determination Accuracy in Dried Blood SpotsElena Bonet Estruch, María J López-Lara, Eva N Gutiérrez-Cortizo, et al.
Endocrinologia, Diabetes Y Nutricion|March 11, 2018
Cascade screening program for familial hypercholesterolemiaPatricia Rubio-Marín, Alfredo Michán-Doña, Juan Maraver-Delgado, et al.
Clinical Therapeutics|April 7, 2005
Long-term safety and, tolerability profiles and lipid-modifying efficacy of ezetimibe coadministered with ongoing simvastatin treatment: a multicenter, randomized, double-blind, placebo-controlled, 48-week extension studyLuis Masana, Pedro Mata, Claude Gagné, et al.
Human Mutation|July 9, 2004
Molecular characterization of familial hypercholesterolemia in Spain: identification of 39 novel and 77 recurrent mutations in LDLRPilar Mozas, Sergio Castillo, Diego Tejedor, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 16, 2005
Tendon xanthomas in familial hypercholesterolemia are associated with cardiovascular risk independently of the low-density lipoprotein receptor gene mutationFernando Civeira, Sergio Castillo, Rodrigo Alonso, et al.
Revista Espanola De Cardiologia|August 2, 2003
[Differences in clinical presentation between subjects with a phenotype of familial hypercholesterolemia determined by defects in the LDL-receptor and defects in Apo B-100]Ignacio García-Alvarez, Sergio Castillo, Pilar Mozas, et al.
Clinical Biochemistry|March 26, 2009
Genetic diagnosis of familial hypercholesterolemia using a DNA-array based platformRodrigo Alonso, Joep C Defesche, Diego Tejedor, et al.
Nature Reviews. Cardiology|January 25, 2020
Familial hypercholesterolaemia: evolving knowledge for designing adaptive models of careGerald F Watts, Samuel S Gidding, Pedro Mata, et al.
Clinical Chemistry|September 26, 2006
Comparison of DNA array platform vs DNA sequencing as genetic diagnosis tools for familial hypercholesterolemiaDiego Tejedor, Sergio Castillo, Pilar Mozas, et al.
Pageof 15

Showing results (71-80 of 144) with videos related to

Sort By:
Pageof 15
Journal of Clinical Lipidology|July 29, 2022
Predicting resilience in heterozygous familial hypercholesterolaemia: A cohort study of octogenarian patientsLeopoldo Pérez de Isla, Rodrigo Alonso, Rosa Argüeso, et al.
Diagnostics (Basel, Switzerland)|September 14, 2024
Total Cholesterol Determination Accuracy in Dried Blood SpotsElena Bonet Estruch, María J López-Lara, Eva N Gutiérrez-Cortizo, et al.
Endocrinologia, Diabetes Y Nutricion|March 11, 2018
Cascade screening program for familial hypercholesterolemiaPatricia Rubio-Marín, Alfredo Michán-Doña, Juan Maraver-Delgado, et al.
Clinical Therapeutics|April 7, 2005
Long-term safety and, tolerability profiles and lipid-modifying efficacy of ezetimibe coadministered with ongoing simvastatin treatment: a multicenter, randomized, double-blind, placebo-controlled, 48-week extension studyLuis Masana, Pedro Mata, Claude Gagné, et al.
Human Mutation|July 9, 2004
Molecular characterization of familial hypercholesterolemia in Spain: identification of 39 novel and 77 recurrent mutations in LDLRPilar Mozas, Sergio Castillo, Diego Tejedor, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 16, 2005
Tendon xanthomas in familial hypercholesterolemia are associated with cardiovascular risk independently of the low-density lipoprotein receptor gene mutationFernando Civeira, Sergio Castillo, Rodrigo Alonso, et al.
Revista Espanola De Cardiologia|August 2, 2003
[Differences in clinical presentation between subjects with a phenotype of familial hypercholesterolemia determined by defects in the LDL-receptor and defects in Apo B-100]Ignacio García-Alvarez, Sergio Castillo, Pilar Mozas, et al.
Clinical Biochemistry|March 26, 2009
Genetic diagnosis of familial hypercholesterolemia using a DNA-array based platformRodrigo Alonso, Joep C Defesche, Diego Tejedor, et al.
Nature Reviews. Cardiology|January 25, 2020
Familial hypercholesterolaemia: evolving knowledge for designing adaptive models of careGerald F Watts, Samuel S Gidding, Pedro Mata, et al.
Clinical Chemistry|September 26, 2006
Comparison of DNA array platform vs DNA sequencing as genetic diagnosis tools for familial hypercholesterolemiaDiego Tejedor, Sergio Castillo, Pilar Mozas, et al.
Pageof 15